Last updated: 28 January 2021 at 7:24pm EST

Franco Valle Net Worth




The estimated Net Worth of Franco Valle is at least 1.01 百万$ dollars as of 11 January 2021. Franco Valle owns over 3,247 units of Eidos Therapeutics Inc stock worth over 213,501$ and over the last 5 years Franco sold EIDX stock worth over 797,906$.

Franco Valle EIDX stock SEC Form 4 insiders trading

Franco has made over 6 trades of the Eidos Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Franco exercised 3,247 units of EIDX stock worth 23,508$ on 11 January 2021.

The largest trade Franco's ever made was selling 10,643 units of Eidos Therapeutics Inc stock on 7 October 2020 worth over 797,906$. On average, Franco trades about 3,189 units every 39 days since 2020. As of 11 January 2021 Franco still owns at least 1,747 units of Eidos Therapeutics Inc stock.

You can see the complete history of Franco Valle stock trades at the bottom of the page.



What's Franco Valle's mailing address?

Franco's mailing address filed with the SEC is C/O EIDOS THERAPEUTICS, INC., 101 MONTGOMERY STREET, SUITE 2000, SAN FRANCISCO, CA, 94104.

Insiders trading at Eidos Therapeutics Inc

Over the last 6 years, insiders at Eidos Therapeutics Inc have traded over 18,169,563$ worth of Eidos Therapeutics Inc stock and bought 30,345,136 units worth 349,599,962$ . The most active insiders traders include Capital Management, L.P.Ra ...Pharma, Inc. Bridge BioRajeev M. Shah. On average, Eidos Therapeutics Inc executives and independent directors trade stock every 13 days with the average trade being worth of 52,576,942$. The most recent stock trade was executed by Pharma, Inc. Bridge Bio on 26 January 2021, trading 14,428,836 units of EIDX stock currently worth 1,763,348,048$.



What does Eidos Therapeutics Inc do?



Complete history of Franco Valle stock trades at Eidos Therapeutics Inc

インサイダー
取引
取引
合計金額
Franco Valle
上席副社長、Finance
オプション行使 23,508$
11 Jan 2021
Franco Valle
上席副社長、Finance
オプション行使 11,751$
9 Nov 2020
Franco Valle
上席副社長、Finance
販売 797,906$
7 Oct 2020
Franco Valle
上席副社長、Finance
オプション行使 14,480$
20 Apr 2020
Franco Valle
上席副社長、Finance
オプション行使 36,200$
26 Mar 2020
Franco Valle
上席副社長、Finance
オプション行使 21,720$
2 Mar 2020


Eidos Therapeutics Inc executives and stock owners

Eidos Therapeutics Inc executives and other stock owners filed with the SEC include: